← Leaderboards
Rainer F. Storb
Fred Hutchinson Cancer Research Center
$23,835,935
Attributed
$23,877,891
Total exposure
22
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2005–23$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$104,309,455 · 26
By mechanism
P01$103,544,665 · 25
R01$764,790 · 1
Top collaborators
- Brenda Marie Sandmaier16 shared
Most similar at Fred Hutchinson Cancer Research Center
Same institution · by research overlap
- George Earl Georges$15,152,269
- Brenda Marie Sandmaier$22,185,663
- David G Maloney$3,575,748
- Bart L Scott$682,425
- Lauri M. Burroughs$850,274
Others in their field
Top investigators on “Hematopoietic”
- Mary M Horowitz · Medical College Of Wisconsin$225,743,807
- Hans-Peter Kiem · Fred Hutchinson Cancer Center$75,636,774
- Effie W Petersdorf · Fred Hutchinson Cancer Research Center$46,290,940
- Megan Sykes · Columbia University Health Sciences$41,013,082
- David T Scadden · Massachusetts General Hospital$37,607,985
- Bruce R. Blazar · University Of Minnesota$36,961,789
Research focus
HematopoieticConditioningTransplantationPre-ClinicalBaseGraft-Vs-Host DiseaseCanis FamiliarisRegimenChimerismAllogenicHematopoietic Cell TransplantationMonoclonal AntibodiesNatural ImmunosuppressionT-LymphocyteProgramsHematologic NeoplasmsToxic EffectPreventTranslatingAllograftingGrantProtocols DocumentationCellsComorbidity
Grant awards (126)
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge$2,074,913
P01 · FY2023 · CA
Core C: Administrative Services$223,757
P01 · FY2023 · CA · contact PI
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge$2,071,892
P01 · FY2022 · CA
Core C: Administrative Services$209,664
P01 · FY2022 · CA · contact PI
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge$1,449,399
P01 · FY2021 · CA
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge$679,409
P01 · FY2021 · CA
Core C: Administrative Services$241,565
P01 · FY2021 · CA · contact PI
Core C: Administrative Services$223,758
P01 · FY2021 · CA · contact PI
Preventing Relapse After Non-myeloablative Stem Cell Transplantation: The Final Challenge$1,846,796
P01 · FY2020 · CA
Core C: Administrative Services$187,686
P01 · FY2020 · CA · contact PI
Hematopoietic Chimerism after Stem Cell Allografts$984,084
P01 · FY2019 · CA · contact PI
Project 1: Cell Therapy for Correction of Blood Disorders$458,385
P01 · FY2019 · HL · contact PI
Administrative Services Core$248,377
P01 · FY2019 · HL · contact PI
Hematopoietic Chimerism after Stem Cell Allografts$892,086
P01 · FY2018 · CA · contact PI
Project 1: Cell Therapy for Correction of Blood Disorders$464,475
P01 · FY2018 · HL · contact PI
Project 1: Preventing Acute GVHD and Treating Chronic GVHD in a Canine Model$289,700
P01 · FY2018 · CA · contact PI
Administrative Services Core$252,644
P01 · FY2018 · HL · contact PI
Core C: Administrative Services$111,917
P01 · FY2018 · CA · contact PI
Program Integration and management$8,886
P01 · FY2018 · CA · contact PI
Cell and Gene Therapy for Nonmalignant Blood Disorders$2,578,045
P01 · FY2017 · HL · contact PI
Hematopoietic Chimerism after Stem Cell Allografts$2,023,730
P01 · FY2017 · CA · contact PI
Project 1: Preventing Acute GVHD and Treating Chronic GVHD in a Canine Model$613,799
P01 · FY2017 · CA · contact PI
Project 1: Cell Therapy for Correction of Blood Disorders$470,573
P01 · FY2017 · HL · contact PI
Administrative Services Core$257,075
P01 · FY2017 · HL · contact PI
Core C: Administrative Services$234,830
P01 · FY2017 · CA · contact PI
Program Integration and management$18,647
P01 · FY2017 · CA · contact PI
Cell and Gene Therapy for Nonmalignant Blood Disorders$2,599,641
P01 · FY2016 · HL · contact PI
Hematopoietic Chimerism after Stem Cell Allografts$2,023,730
P01 · FY2016 · CA · contact PI
Project 1: Preventing Acute GVHD and Treating Chronic GVHD in a Canine Model$613,799
P01 · FY2016 · CA · contact PI
Project 1: Cell Therapy for Correction of Blood Disorders$477,530
P01 · FY2016 · HL · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$334,135
P01 · FY2016 · CA · contact PI
Administrative Services Core$261,502
P01 · FY2016 · HL · contact PI
Core C: Administrative Services$234,830
P01 · FY2016 · CA · contact PI
Program Integration and management$18,647
P01 · FY2016 · CA · contact PI
Cell and Gene Therapy for Nonmalignant Blood Disorders$2,670,915
P01 · FY2015 · HL · contact PI
Hematopoietic Chimerism after Stem Cell Allografts$2,019,079
P01 · FY2015 · CA · contact PI
Project 1: Preventing Acute GVHD and Treating Chronic GVHD in a Canine Model$613,799
P01 · FY2015 · CA · contact PI
Project 1: Cell Therapy for Correction of Blood Disorders$481,666
P01 · FY2015 · HL · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$334,135
P01 · FY2015 · CA · contact PI
Administrative Services Core$263,768
P01 · FY2015 · HL · contact PI
Core C: Administrative Services$234,830
P01 · FY2015 · CA · contact PI
Program Integration and management$18,647
P01 · FY2015 · CA · contact PI
Hematopoietic Chimerism after Stem Cell Allografts$1,846,366
P01 · FY2014 · CA · contact PI
Project 1: Preventing Acute GVHD and Treating Chronic GVHD in a Canine Model$627,064
P01 · FY2014 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$324,112
P01 · FY2014 · CA · contact PI
Core C: Administrative Services$240,351
P01 · FY2014 · CA · contact PI
Program Integration and management$19,085
P01 · FY2014 · CA · contact PI
Mixed Hematopoietic Chimerism After Stem Cell Allografts$1,788,455
P01 · FY2013 · CA · contact PI
Establishing Mixed Hematopoietic Chimerism in a Canine Model$610,796
P01 · FY2013 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$314,087
P01 · FY2013 · CA · contact PI
Administrative Services$136,968
P01 · FY2013 · CA · contact PI
Mixed Hematopoietic Chimerism After Stem Cell Allografts$1,909,574
P01 · FY2012 · CA · contact PI
Establishing Mixed Hematopoietic Chimerism in a Canine Model$697,523
P01 · FY2012 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$334,135
P01 · FY2012 · CA · contact PI
Administrative Services$142,079
P01 · FY2012 · CA · contact PI
Mixed Hematopoietic Chimerism After Stem Cell Allografts$1,909,490
P01 · FY2011 · CA · contact PI
Establishing Mixed Hematopoietic Chimerism in a Canine Model$688,758
P01 · FY2011 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$463,879
P01 · FY2011 · CA · contact PI
Administrative Services$144,379
P01 · FY2011 · CA · contact PI
Stem Cell Transplantation: Basic/Clinical Research$2,947,491
P01 · FY2010 · HL · contact PI
Mixed Hematopoietic Chimerism After Stem Cell Allografts$1,955,836
P01 · FY2010 · CA · contact PI
Establishing Mixed Hematopoietic Chimerism in a Canine Model$682,585
P01 · FY2010 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$403,110
P01 · FY2010 · CA · contact PI
Administrative Services$199,804
P01 · FY2010 · HL · contact PI
Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders$160,132
P01 · FY2010 · HL · contact PI
Administrative Services$144,156
P01 · FY2010 · CA · contact PI
Stem Cell Transplantation: Basic/Clinical Research$2,827,583
P01 · FY2009 · HL · contact PI
Mixed Hematopoietic Chimerism After Stem Cell Allografts$1,991,605
P01 · FY2009 · CA · contact PI
Establishing Mixed Hematopoietic Chimerism in a Canine Model$610,689
P01 · FY2009 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$452,035
P01 · FY2009 · CA · contact PI
Administrative Services$194,418
P01 · FY2009 · HL · contact PI
Administrative Services$171,432
P01 · FY2009 · CA · contact PI
Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders$158,675
P01 · FY2009 · HL · contact PI
Stem Cell Transplantation: Basic/Clinical Research$2,660,181
P01 · FY2008 · HL · contact PI
Mixed Hematopoietic Chimerism after Stem Cell Allografts$2,003,834
P01 · FY2008 · CA · contact PI
Establishing Stable Mixed Hematopoietic Chimerism$700,376
P01 · FY2008 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$443,938
P01 · FY2008 · CA · contact PI
Administrative Services$185,546
P01 · FY2008 · HL · contact PI
Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders$154,231
P01 · FY2008 · HL · contact PI
Stem Cell Transplantation: Basic/Clinical Research$2,604,389
P01 · FY2007 · HL · contact PI
Mixed Hematopoietic Chimerism after Stem Cell Allografts$1,985,492
P01 · FY2007 · CA · contact PI
Establishing Stable Mixed Hematopoietic Chimerism$693,968
P01 · FY2007 · CA · contact PI
Nonmyeloablative Hematopoietic Cell Allotransplants$371,499
P01 · FY2007 · CA · contact PI
Allogeneic Hematopoietic Cell Transplantation for Nonmalignant Disorders$165,780
P01 · FY2007 · HL · contact PI
Administrative Services$109,410
P01 · FY2007 · HL · contact PI
Stem Cell Transplantation: Basic/Clinical Research$2,591,179
P01 · FY2006 · HL · contact PI
Mixed Hematopoietic Chimerism after Stem Cell Allografts$2,019,270
P01 · FY2006 · CA · contact PI
Establishing Stable Mixed Hematopoietic Chimerism$370,985
P01 · FY2006 · CA · contact PI
Administrative Services$189,464
P01 · FY2006 · HL · contact PI
Stem Cell Transplantation$161,513
P01 · FY2006 · HL · contact PI
Stem Cell Transplantation: Basic/Clinical Research$2,178,582
P01 · FY2005 · HL
Mixed Hematopoietic Chimerism after Stem Cell Allografts$2,009,048
P01 · FY2005 · CA
Establishing Stable Mixed Hematopoietic Chimerism$360,179
P01 · FY2005 · CA
Nonmyeloablative Transplants for Nomalignant Disorders$96,676
P01 · FY2005 · HL
Stem Cell Transplantation: Basic/Clinical Research$2,129,389
P01 · FY2004 · HL
Mixed Hematopoietic Chimerism after Stem Cell Allografts$1,876,346
P01 · FY2004 · CA
Establishing Stable Mixed Hematopoietic Chimerism$349,687
P01 · FY2004 · CA
Core C: Administrative Services$99,461
P01 · FY2004 · CA
Nonmyeloablative Transplants for Nomalignant Disorders$95,918
P01 · FY2004 · HL
Core E- Administration$88,614
P01 · FY2004 · HL
Stem Cell Transplantation: Basic/Clinical Research$2,083,203
P01 · FY2003 · HL
MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS$1,737,356
P01 · FY2003 · CA
Nonmyeloablative transplants for nonmalignant disorders$416,641
P01 · FY2003 · HL
Stem Cell Transplantation: Basic/Clinical Research$1,874,531
P01 · FY2002 · HL
MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS$1,690,299
P01 · FY2002 · CA
MIXED HEMATOPOIETIC CHIMERISM IN AN ANIMAL MODEL$215,218
P01 · FY2002 · CA
Nonmyeloablative transplants for nonmalignant disorders$0
P01 · FY2002 · HL
NONMYELOABLATIVE HEMATOPOIETIC STEM CELL ALLOTRANSPLANTS$0
P01 · FY2002 · CA
Stem Cell Transplantation: Basic/Clinical Research$1,829,639
P01 · FY2001 · HL
MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS$1,619,171
P01 · FY2001 · CA
IMMUNOLOGIC STUDIES IN STEM CELL GRAFTS FOR MALIGNANCIES$1,383,491
P01 · FY2001 · CA
HEMATOPOIETIC GROWTH FACTORS IN A CANINE STEM CELL MODEL$387,470
R01 · FY2001 · DK
MIXED HEMATOPOIETIC CHIMERISM IN AN ANIMAL MODEL$215,218
P01 · FY2001 · CA
Nonmyeloablative transplants for nonmalignant disorders$0
P01 · FY2001 · HL
CORE--BIOSTATISTICAL SUPPORT$0
P01 · FY2001 · CA
PREVENTION AND TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE$0
P01 · FY2001 · CA
STEM CELL TRANSPLANTATION--BASIC/CLINICAL RESEARCH$2,150,532
P01 · FY2000 · HL
MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS$1,398,609
P01 · FY2000 · CA
IMMUNOLOGIC STUDIES IN STEM CELL GRAFTS FOR MALIGNANCIES$1,343,906
P01 · FY2000 · CA
HEMATOPOIETIC GROWTH FACTORS IN A CANINE STEM CELL MODEL$377,320
R01 · FY2000 · DK
PREVENTION AND TREATMENT OF ACUTE GRAFT VERSUS HOST DISEASE$346,443
P01 · FY2000 · CA
CORE--BIOSTATISTICAL SUPPORT$326,368
P01 · FY2000 · CA
MIXED HEMATOPOIETIC CHIMERISM IN AN ANIMAL MODEL$241,761
P01 · FY2000 · CA
MIXED HEMATOPOIETIC CHIMERISM IN AN ANIMAL MODEL$215,218
P01 · FY2000 · CA
STEM CELL TRANSPLANTS FROM HLA-IDENTICAL FAMILY MEMBERS$175,711
P01 · FY2000 · HL
MIXED HEMATOPOIETIC CHIMERISM AFTER STEM CELL ALLOGRAFTS$172,998
P01 · FY2000 · CA